2m 2m 2m 2m 2m 2m 2m
LYELL IMMUNPHRM (LYEL)
NASDAQ
$12.63-$2.26 (-15.18%)
Price as of Jun 03, 2026 7:47 PM EDT- $404.4MMarket Cap
- 86.36%1-Year Change
- BiotechnologyIndustry
LYELL IMMUNPHRM (LYEL)
$12.63-$2.26 (-15.18%)
LYEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.89 | ||
Change | -$2.26 (-13.18%) | ||
Open | $17.15 | ||
High | $17.16 | ||
Low | $14.71 | ||
Previous Close | $17.15 | ||
Volume | 117,955 | ||
30-Day Average Volume | 73,833 | ||
1-Week Change | -9.04% | ||
1-Month Change | -28.52% | ||
1-Year Change | 86.36% | ||
3-Year Change | -78.73% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 23.3M | ||
Total Assets | $350.6M | ||
Market Cap | $404.4M | ||
Enterprise Value | $313.6M | ||
Period: QTR TTM FY | |||
Revenue | $2,000.00 | ||
Net Income | -$24.2M | ||
Free Cash Flow | -$38.6M | ||
EBIT | -$24.2M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $230.4M | ||
EPS | -$1.10 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 156,805 | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/02/2025 | ||
Earnings & Revenue